NATHBIOGEN2024-04-012024-06-30 NATHBIOGEN2024-04-012024-06-30in-bse-fin:OneOperatingExpenses01Member NATHBIOGEN2024-04-012024-06-30in-bse-fin:OneOperatingExpenses02Member NATHBIOGEN2024-06-30 iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 537291 NATHBIOGEN NOTLISTED Nath Bio-Genes (India) Limited Equity 2024-04-01 2025-03-31 2024-08-07 2024-07-30 INR Lakhs First quarter 13:00:00 15:30:00 2024-08-07 2024-08-07 Not applicable Single segment SEEDS CULTIVATION 2024-04-01 2024-06-30 Unaudited Consolidated 2438751000.00 1302000.00 2440053000.00 663882000.00 28215000.00 537053000.00 67390000.00 22407000.00 8250000.00 776854000.00 2104051000.00 336002000.00 0.00 336002000.00 2453000.00 0.00 2453000.00 0.00 333549000.00 0.00 0.00 0.00 0.00 333549000.00 -1242000.00 332307000.00 0.00 0.00 0.00 0.00 190040000.00 10 17.49 17.49 0.00 0.00 17.49 17.49 Notes. 1) The Financial results were reviewed by the Audit Committee in meeting held on 06th August 2024 and were thereafter approevd by the Board of Directors at its meeting held on 07th August 2024. 2) The Company is dealing in one major segment i.e. horticulture crops. 3) The results have been consolidated with Nath Bio-Genes CA, Uzbekistan, where company holds 90% of equity 4) Investor Complaint Opening - 0, Received and solved - 1, Closing Balance -0. 5) The figure have been regrouped/ rearranged where ever necessary. Other Expenses 76607000.00 Selling and Distribution Expenses 700247000.00 1242000.00 0.00